Table 1. Q2 2021 Corporate Quarterly Updates: Small and Mid-Cap Biotech

Table 1. Ticker, drug, and indication for biopharma companies with current (7/30/21) market cap under $5B that receive revenue from approved drugs thru their or their partners commercialization efforts